MarketCap
Facebook
X
TelegramQuidel Corporation Operating Cycle 2011-2026 | QDEL
Annual Operating Cycle Quidel Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 68.4 | 417 | 489 | 527 | 711 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 711 | 68.4 | 443 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
259 | $ 9.26 | - | $ 617 M |  USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 24.7 | - | $ 686 M | USA |
 |
DexCom
DXCM
|
202 | $ 66.09 | - | $ 25.8 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 14.6 | - | $ 1.89 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.38 | 0.06 % | $ 495 M | USA |
 |
DarioHealth Corp.
DRIO
|
227 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 103.08 | - | $ 8.5 B |  Irlanda |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
128 | $ 573.29 | - | $ 46.1 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 466.6 | - | $ 13.5 B | USA |
 |
Illumina
ILMN
|
198 | $ 124.4 | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.62 | - | $ 428 M | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Natera
NTRA
|
81.5 | $ 196.15 | - | $ 19.3 B | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
405 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
285 | $ 1.17 | - | $ 812 M | USA |
 |
Pacific Biosciences of California
PACB
|
244 | $ 1.35 | - | $ 405 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 17.52 | 0.92 % | $ 392 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 165.13 | - | $ 8.18 B | USA |
 |
Personalis
PSNL
|
55.8 | $ 7.32 | - | $ 434 M | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 4.59 | - | $ 2.46 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
79.2 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | $ 31.83 | - | $ 1.62 B | USA |
 |
RadNet
RDNT
|
34.5 | $ 59.41 | - | $ 4.47 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 488.85 | - | $ 184 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | - | $ 61.9 M | Irlanda |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 6.56 | - | $ 274 M | USA |